Literature DB >> 15455213

Proteomic identification of collagens and related proteins in human fibroblasts.

J E Oh1, K Krapfenbauer, G Lubec.   

Abstract

Fibroblasts are used for diagnosis of a series of metabolic diseases and are particularly suitable for the diagnosis of collagen disorders. We aimed to generate a skin fibroblast map that would be suitable for the concomitant determination of collagen and collagen-related proteins.A human skin fibroblast cell line was cultivated, homogenised, proteins extracted and subject to two-dimensional gel electrophoresis with subsequent in-gel-digestion of protein spots and mass spectrometrical identification (MALDI-TOF). Collagen alpha1 (I) chain precursor, collagen alpha1 (III) chain precursor, collagen alpha2 (VI) precursor and collagen modifying enzymes prolyl 4-hydroxylase alpha-2-subunit precursor, procollagen-lysine 2-oxoglutarate 5-dioxygenase 1 and 2, protein disulfide isomerase ER-60 precursor and peptidyl-prolyl cis-trans isomerase were among the abundant proteins. The finding of collagen and collagen-related structures as well as the identification of other metabolic enzyme systems on one 2D gel may propose the use of this proteomic method for further characterization of collagen and collagen-related proteins or for preliminary screening of metabolic disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15455213     DOI: 10.1007/s00726-004-0128-y

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  2 in total

1.  Analysis of pressure ulcer wound fluid using two-dimensional electrophoresis.

Authors:  Jennifer T Wyffels; Kristin M Fries; Jason S Randall; Daniel S Ha; Christa A Lodwig; Michael S Brogan; Marlene Shero; Laura E Edsberg
Journal:  Int Wound J       Date:  2010-05-18       Impact factor: 3.315

2.  Bottom-Up Mass Spectrometry-Based Proteomics as an Investigative Analytical Tool for Discovery and Quantification of Proteins in Biological Samples.

Authors:  Ravi Amunugama; Richard Jones; Michael Ford; David Allen
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-11       Impact factor: 4.730

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.